13F filing recap · Q3 2025
What did Icahn Capital LP buy in Q3 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$9.14B
Positions
13
Estimated turnover
12.5%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Icahn Capital opened new positions in Echostar Corporation and Monro, Inc. and exited Bausch Health Companies entirely. The fund also added to Centuri Holdings substantially, increased International Flavors & Fragrances and Icahn Enterprises, and trimmed Southwest Gas Holdings.